Depression is one of the most common mental health conditions, but not everyone responds to traditional antidepressant medications. For some individuals, symptoms continue despite trying multiple treatment options, a condition known as treatment-resistant depression (TRD).
In recent years, SPRAVATO treatment has emerged as an innovative option for adults living with treatment-resistant depression. Approved by the U.S. Food and Drug Administration (FDA), SPRAVATO offers a different approach by targeting brain pathways that conventional antidepressants don’t directly affect.
This guide explains what SPRAVATO treatment is, how it works, its benefits, the treatment process, and who may be an ideal candidate.
What Is SPRAVATO Treatment?
SPRAVATO treatment is an FDA-approved prescription therapy that contains esketamine, a medication administered as a nasal spray under medical supervision. Unlike traditional antidepressants that primarily affect serotonin, SPRAVATO works on glutamate pathways, helping restore communication between brain cells involved in mood regulation.
It is specifically approved for adults with treatment-resistant depression who have not achieved adequate improvement after trying multiple antidepressant medications.
Patients interested in learning more about SPRAVATO treatment can explore eligibility, the treatment process, and clinical details through Family Care Psychiatry’s dedicated SPRAVATO service page.
How Does SPRAVATO Treatment Work?
One of the biggest differences between SPRAVATO and traditional antidepressants is how the medication affects the brain.
SPRAVATO contains esketamine, which acts on NMDA receptors involved in regulating glutamate. This process supports the formation of healthier neural connections, which may help improve symptoms of depression in eligible patients.
If you’d like a deeper explanation of the science behind this therapy, Family Care Psychiatry provides a helpful resource explaining how SPRAVATO treatment works and what patients can expect before, during, and after therapy.
Benefits of SPRAVATO Treatment
SPRAVATO treatment offers several potential advantages for patients whose depression has not improved with conventional medications.
FDA-Approved for Treatment-Resistant Depression
SPRAVATO is one of the few FDA-approved treatments specifically developed for adults with treatment-resistant depression.
Different From Traditional Antidepressants
Rather than focusing on serotonin, SPRAVATO targets glutamate activity in the brain, offering an alternative treatment approach for appropriate patients.
Personalized Care
Treatment schedules are adjusted according to each patient’s symptoms, progress, and response to therapy.
Outpatient Procedure
SPRAVATO is administered in a certified treatment center, allowing patients to return home the same day after the required observation period.
What Happens During a SPRAVATO Treatment Session?
Understanding the treatment process can help reduce uncertainty before beginning therapy.
Initial Psychiatric Evaluation
Your psychiatrist will review:
- Medical history
- Depression diagnosis
- Previous antidepressant treatments
- Current medications
- Overall physical and mental health
This evaluation helps determine whether SPRAVATO treatment is appropriate for your situation.
Medication Administration
Patients self-administer the nasal spray under the supervision of trained healthcare professionals in a certified medical facility.
Following administration, patients remain under observation for approximately two hours so healthcare providers can monitor temporary side effects and ensure the treatment is well tolerated.
Follow-Up Visits
Treatment usually starts with more frequent appointments before gradually transitioning to a maintenance schedule based on individual progress.
Who Is a Good Candidate for SPRAVATO Treatment?
SPRAVATO treatment may be recommended for adults who:
- Have treatment-resistant depression
- Have tried at least two antidepressants without sufficient improvement
- Can attend scheduled in-clinic treatment sessions
- Meet the medical eligibility criteria established by their psychiatrist
A comprehensive psychiatric assessment is essential before beginning treatment.
Possible Side Effects
Like any prescription medication, SPRAVATO may cause side effects.
Some of the most commonly reported temporary side effects include:
- Dizziness
- Drowsiness
- Nausea
- Headache
- Increased blood pressure
- Dissociation or feeling disconnected from surroundings
These effects are generally monitored during the observation period and usually improve before patients leave the clinic.
How Long Does SPRAVATO Treatment Last?
Treatment schedules vary depending on the patient’s needs and response.
Many patients begin with two treatment sessions per week before gradually reducing the frequency during the maintenance phase. Your psychiatrist will develop a personalized treatment plan based on your clinical progress.
Is SPRAVATO Right for Everyone?
SPRAVATO is not intended for every person experiencing depression.
Eligibility depends on several factors, including:
- Diagnosis
- Previous treatment history
- Overall medical condition
- Current medications
- Psychiatric evaluation
Your healthcare provider will determine whether SPRAVATO is an appropriate option based on your individual circumstances.
Final Thoughts
Treatment-resistant depression can be difficult to manage, but advances in mental health care have created new options for patients who have not responded to conventional antidepressants. SPRAVATO treatment offers an evidence-based approach that works differently from traditional medications and may provide meaningful symptom improvement for eligible individuals.
If you believe your current treatment plan isn’t providing the results you need, speaking with a qualified mental health professional can help you explore whether SPRAVATO treatment is the right next step for your recovery journey.